ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc (TMBR)

0.3426
0.00
(0.00%)
Closed December 27 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.3426
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.3426
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TMBR Latest News

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...

Timber Pharmaceuticals Discloses Communication From NYSE American

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for...

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber...

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc...

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled...

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING...

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, Feb. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TMBR - Frequently Asked Questions (FAQ)

What is the current Timber Pharmaceuticals share price?
The current share price of Timber Pharmaceuticals is US$ 0.3426
What is the 1 year trading range for Timber Pharmaceuticals share price?
Timber Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTMCastellum Inc
US$ 1.375
(137.07%)
104.51M
SSYSunlink Health Systems
US$ 1.1509
(49.49%)
10.34M
RYDERyde Group Ltd
US$ 0.4401
(41.97%)
22.6M
KULRKULR Technology Group Inc
US$ 4.7885
(40.01%)
108.49M
OPTTOcean Power Technologies Inc
US$ 0.4447
(35.29%)
92.72M
BTOPBitwise Trendwise BTC ETH and Treasuries Rotation Strategy ETF
US$ 35.0799
(-37.99%)
7.08k
BITCBitwise Trendwise Bitcoin and Treasuries Rotation Strategy ETF
US$ 47.41
(-29.93%)
20.49k
AETHBitwise Trendwise Ether and Treasuries Rotation Strategy ETF
US$ 37.0868
(-12.70%)
5.76k
ETHU2x Ether ETF
US$ 7.7301
(-11.20%)
20.16M
ETHTProshares Ultra Ether ETF
US$ 21.6001
(-10.93%)
1.14M
KULRKULR Technology Group Inc
US$ 4.7885
(40.01%)
108.49M
CTMCastellum Inc
US$ 1.375
(137.07%)
104.51M
OPTTOcean Power Technologies Inc
US$ 0.4447
(35.29%)
92.72M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5.81
(0.17%)
51.69M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.00
(0.76%)
50.46M

Discussion

View Full Feed
Deportes Deportes 5 minutes ago
I trust docsetc, I blow I don't trust! 
ENZC
RealDutch RealDutch 11 minutes ago
I have complained about it many times, internally, about Laxmi responding to IHUB posts and sending a copy to the entire shareholder base. I think it is very damaging. And he agreed and said he would not do it again but he is still doing it. And now he is really crossing the line by telling us not t
ITUP
StockItOut StockItOut 13 minutes ago
This might be a landmark case.
XERI
kabunushi kabunushi 14 minutes ago
Doc, in addition to what you wrote, a financier agreeing to $50M supplemental facility (with no warrants!) is a massive commitment. Please note that the additional $50M is a one-way option - it's NW's sole option, the financier has already fully committed. Yes, pricing will be at a small discount to
NWBO
IceCold8 IceCold8 14 minutes ago
I'd love, for this to run to $2!!!
CGAC
mrfence mrfence 19 minutes ago
FYI, the same man that said that
teach a man to fish
threw money changers out of the temple.
FNMA
shajandr shajandr 21 minutes ago
"100lbStriper
Tuesday, December 24, 2024 4:55:52 PM

NLST In case anyone is worried about a potential BOC retrial, re-read this and you’ll rest easy and have a Merry Christmas"

LOLOL! OK. Shure.

At least DaCourt waited until after Christmas before
NLST
loophole lawyer loophole lawyer 23 minutes ago
https://www.reuters.com/world/americas/trump-says-he-might-demand-panama-hand-over-canal-2024-12-22/
lakers17 lakers17 27 minutes ago
Yep. It's amazing how BCDS is looking like NSA* 2.0. Same playbook. Here are 12 reasons just off the top of my head. Let's review the similarities:

*Looks to have some of the same of the people involved
*Now have NSA* tech which is nothing in the world of crypto and being p
BCDS
loophole lawyer loophole lawyer 31 minutes ago
https://www.nytimes.com/2024/12/26/us/politics/trump-panama-canal.html
jtaylor042 jtaylor042 33 minutes ago
Doesn't NWBO have two consultants who do this work? What it sees as its uplisting hurdles should be easy for someone at the company to define and relay, no?

This line of discussion has always bugged me-it seems if those consultants are paid for anything, the very first thing should
NWBO
Can'tSparTheGhost Can'tSparTheGhost 33 minutes ago
Hmmm...#1 on Breakout Board again...🤗

$PHIL
PHIL
loophole lawyer loophole lawyer 33 minutes ago
https://www.latinnews.com/component/k2/item/103724.html?archive=3&Itemid=6&cat_id=835178:in-brief-nicaragua-refloats-gran-canal-initiative-to-china
oldmystic oldmystic 34 minutes ago
Model: 85 by 09/01/26
https://invst.ly/186z42
AVXL
karlacorn3 karlacorn3 34 minutes ago
Yep. Sadly, one for the annals of Ripey's Believe It Or Not. Unfortunately, not fitting for the Harvard Business Review.

Perplexed because effective communication is not difficult to realize,
K
ITUP
StockItOut StockItOut 39 minutes ago
Wow, Gosh, full-scale production really is a positive signal that XERI is on track to achieving certification.
XERI
loophole lawyer loophole lawyer 39 minutes ago
https://tass.com/world/1890219
gitreal gitreal 41 minutes ago
going in circles about yellow corn tortilla taco factory,

You are the only one saying that. Maybe you're just hungry and need to run out to the local Filiberto's? Try their shrimp burrito, that's pretty good.
AABB
K.K K.K 41 minutes ago
RD what's wrong with you. When you can simply communicate through email then why hub?
ITUP
Renee Renee 42 minutes ago
NVAC delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
NVAC
loophole lawyer loophole lawyer 43 minutes ago
So……President Trump has expressed his opinion that the Panama Canal “may” need to be under the “control” of America. China (and Russia) would need to build the Nicaraguan Canal very quickly. For two reasons…..First, economics. Second, Military presence. In this game..military “TRUMPS” economics……..T
IanFromSI IanFromSI 44 minutes ago
…. Or you could have a good look at what happened to Momenta(MNTA) and its ability to protect its IP.

…. Twice in a row.
mascale mascale 46 minutes ago
Peoples worldwide know this: AI Overview
Learn more Yes, according to available information, the management of Hiru Corporation is connected to Qatar, with key board members and control block holders being based in Qatar, including a member of the Qatari royal family; the company's primary f
HIRU
skitahoe skitahoe 47 minutes ago
It's been many years since an article in the NY Times took a company from $1 to over $100. It was about Judah Folkman and it suggested that if he were given 2 years he'd cure cancer. It's true, he was curing cancer in mice, but unfortunately it didn't translate to people. The company came right b
NWBO
BDEZ BDEZ 48 minutes ago
Convention of States @COSProject needed

Your Recent History

Delayed Upgrade Clock